Skip to main content
TipRanks
Go Ultimate75% OFF

Kerry D. Ingalls Insider Profile

4 Followers

Kerry D. Ingalls, former COO at Poseida Therapeutics, holds 55.00K shares in Poseida Therapeutics (Ticker: PSTX). Most recently, Kerry D. Ingalls Bought 3,000 shares of Poseida Therapeutics on Mar 18, 2022 for an estimated value of $11.94K.

Kerry D. Ingalls's Trading History

PSTX
Poseida Therapeutics
Mar 18, 2022―Informative Buy11.94K$522.50K
PSTX
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 18, 2022Informative Buy$11.94K3,000$3.98-15.30%
Mar 01, 2022Uninformative Buy$0.0050,000$0.00―
Nov 18, 2021Informative Buy$14.00K2,000$7.00-42.30%

You May Also Like

Kerry D. Ingalls insider profile FAQ

What is the percentage of profitable transactions made by Kerry D. Ingalls?
The percentage of profitable transactions made by Kerry D. Ingalls is 0%.
What is the average return per transaction made by Kerry D. Ingalls?
The average return per transaction made by Kerry D. Ingalls is -28.80%.
What stocks does Kerry D. Ingalls hold?
Kerry D. Ingalls holds: PSTX stocks.
What was Kerry D. Ingalls’s latest transaction?
Kerry D. Ingalls’s latest transaction was an Informative Buy of $11.94K.
What was Kerry D. Ingalls's most profitable transaction?
Kerry D. Ingalls’s most profitable transaction was an Informative Buy of PSTX stock on March 18, 2022. The return on the trade was -15.30%.
What is Kerry D. Ingalls's role in Poseida Therapeutics?
Kerry D. Ingalls's role in Poseida Therapeutics is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.